Four-week sales slump at Rite Aid
CAMP HILL, Pa. Rite Aid on Thursday posted a 2.5% same-store sales decrease for the four weeks ended June 26, with front-end same-store sales declining by 1.1% and pharmacy same-store sales, which included an approximate 157 basis points negative impact from new generic introductions, declining 3.1%.
Prescriptions filled at comparable stores decreased 3.7% over the prior-year period.
Total drug store sales for the four-week period decreased 3.3% to $1.9 billion. Prescription revenue accounted for 67.4% of drug store sales, and third-party prescription revenue represented 96.3% of pharmacy sales.
On June 26, the company operated 4,759 stores, compared with 4,822 stores in the like period a year ago.
Pampers by Cynthia Rowley hitting Target shelves in July
CINCINNATI Pampers has teamed up with renowned fashion designer Cynthia Rowley to bring fashionable diapers to Target shoppers this summer.
Pampers by Cynthia Rowley will be available in 11 colorful styles — for boys and girls — beginning in mid July at Target stores and on Target.com. Pampers by Cynthia Rowley incorporate a beautiful look and feel — giving discerning parents high performance, value and choice of style. The diaper collection, which will be available in pastel designs, including madras, stripes and printed ruffles, is suited specifically to babies and toddlers and delivers the perfect blend of utility and aesthetics.
“Of course parents want the very best for their little ones,” said Jodi Allen, Procter & Gamble’s VP North America baby care. “We also know that sometimes it’s the little things — like how a baby is clothed — that can bring added joy to mom and dad. While performance always comes first, we know that design is also important to parents. We’re pleased to introduce the first diaper line that brings together the best of these two worlds.”
Eisai, SuperGen release data for Dacogen trial
DUBLIN, Calif. Japanese drug maker Eisai has released data on a late-stage clinical trial of a drug for leukemia, Eisai’s development partner said Wednesday.
SuperGen said that while the injectable drug Dacogen (decitabine) did not show statistically significant superiority in overall survival in elderly patients with acute myeloid leukemia compared over treatments given to patients in the control group, “a trend was evident.”
Based on findings, Eisai plans to submit a regulatory application to the Food and Drug Administration seeking approval for Dacogen as a treatment for elderly patients with AML. The drug already is approved to treat myelodysplastic syndromes.